Venkata K. Yellepeddi, PhD, RPh

Research Interests

  • Pediatric formulations
  • Pediatric pharmacokinetic modeling
  • Nanotechnology for cancer diagnosis and treatment
  • Non-Viral Gene/Nucleic Acid Delivery
  • Pharmacokinetics of nanotechnology-based formulations
  • Oral Delivery
  • Formulation and stability studies for compounded formulations
  • Active learning strategies for teaching pharmaceutics and pharmacokinetics


  • English
  • Hindi
  • Telugu

Academic Information

  • Departments: Pediatrics - Research Associate Professor, Pharmaceutics and Pharmaceutical Chemistry - Adjunct Assistant Professor
  • Divisions: Pediatric Clinical Pharmacology

Board Certification

  • American Board of Clinical Pharmacology
  • National Association of Boards of Pharmacy

Academic Bio

Dr. Yellepeddi is Research Associate Professor in the Division of Clinical Pharmacology, Department of Pediatrics, University of Utah. Dr. Yellepeddi is an Adjunct Assistant Professor at the Department of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, University of Utah.

Dr. Yellepeddi’s research interests include the development of age-appropriate pediatric formulations and model informed pediatric drug development. He is currently working on research projects involving the development of a nasal formulation for the treatment of pediatric migraine and oral formulation for the postnatal therapy of cerebral palsy. His future research projects include Physiologically Based Pharmacokinetic (PBPK) modeling in pediatrics and development of in vitro models simulating microenvironments of various pediatric organs in normal and disease conditions. In addition, he is interested in the pharmacokinetics of nanotechnology-based therapeutics for the treatment of various disease conditions.

Dr. Yellepeddi is a licensed pharmacist in the State of Utah and advises pharmacists and pharmacy students on clinical pharmacology and compounding sterile and nonsterile dosage forms. Dr. Yellepeddi is a former chair of the American Association of Pharmaceutical Sciences, Rocky Mountain Discussion Group and item-writer for the National Association of Boards of Pharmacy (NABP). His teaching interests include drug development for medical students, basic and clinical pharmacokinetics, and formulation and drug delivery for pediatrics and adults.

Education History

Type School Degree
Fellowship Division of Clinical Pharmacology, Department of Pediatrics, University of Utah
Clinical Pharmacology
Certification David Eccles School of Business, University of Utah
Health Science Leadership Development Program
Doctoral Training Texas A&M Health Science Center
Major: Medical Sciences; Specialization: Pharmaceutics & Drug Delivery
Research Fellow Indian Institute of Chemical Technology
Pharmaceutics, Drug Delivery, Pharmacokinetics, Pharmacology & Toxicology
Senior Research Fellow
Undergraduate Kakatiya University

Global Impact

Education History

Type School Degree Country
Research Fellow Indian Institute of Chemical Technology
Pharmaceutics, Drug Delivery, Pharmacokinetics, Pharmacology & Toxicology
Senior Research Fellow India
Undergraduate Kakatiya University
B.Pharm India

Selected Publications

Journal Article

  1. Bolla PK, Gote V, Singh M, Yellepeddi VK, Patel M, Pal D, Gong X, Sambalingam D, Renukuntla J (2020). Preparation and characterization of lutein loaded folate conjugated polymeric nanoparticles. J Microencapsul, 37(7), 502-516.
  2. Biltaji E, Enioutina EY, Yellepeddi V, Rower JE, Sherwin CMT, Ward RM, Lemons RS, Constance JE (2020). Supportive care medications coinciding with chemotherapy among children with hematologic malignancy. Leuk Lymphoma, 61(8), 1920-1931.
  3. Rower JE, King AD, Wilkins D, Wilkes J, Yellepeddi V, Maese L, Lemons RS, Constance JE (2020). Dronabinol Prescribing and Exposure Among Children and Young Adults Diagnosed with Cancer. (Epub ahead of print) J Adolesc Young Adult Oncol.
  4. Yellepeddi V, Sayre C, Burrows A, Watt K, Davies S, Strauss J, Battaglia M (2020). Stability of extemporaneously compounded amiloride nasal spray. PLoS ONE, 15(7), e0232435.
  5. Yellepeddi VK, Baker OJ (2019). Predictive modeling of aspirin-triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome. Clin Exp Dent Res, 6(2), 225-235.
  6. Yellepeddi VK, Ghandehari H (2019). Pharmacokinetics of oral therapeutics delivered by dendrimer-based carriers. Expert Opin Drug Deliv, 16(10), 1051-1061.
  7. Bolla PK, Meraz CA, Rodriguez VA, Deaguero I, Singh M, Yellepeddi VK, Renukuntla J (2019). Clotrimazole Loaded Ufosomes for Topical Delivery: Formulation Development and In-Vitro Studies. Molecules, 24(17).
  8. Burrows AC, Yellepeddi VK, Snyder S, Wakefield M, Jackson D, Huynh J, Nguyen K, Sayre CL (2019). Development and Validation of a Stability-indicating High-performance Liquid Chromatographic Method for Quantification of Progesterone in Compounded Glycerinated Gelatin Troches. Int J Pharm Compd, 23(4), 340-350.
  9. Sayre CL, Cox C, Velazquez G, Le MT, Nguyen AH, Ramos M, Burrows A, Yellepeddi VK (2019). Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets. Int J Pharm Compd, 23(1), 62-64.
  10. Yellepeddi VK, Joseph A, Nance E (2019). Pharmacokinetics of nanotechnology-based formulations in pediatric populations. Adv Drug Deliv Rev, 151-152, 44-55.
  11. Upadhyayula SM, Mutheneni SR, Kumaraswamy S, Kadiri MR, Pabbisetty SK, Yellepeddi VS (2012). Filaria monitoring visualization system: a geographical information system-based application to manage lymphatic filariasis in Andhra Pradesh, India. Vector Borne Zoonotic Dis, 12(5), 418-27.


  1. Yellepeddi VK, Joseph A, Nance E (). Pharmacokinetics of Nanotechnology-Based Formulations in Pediatric Populations. [Review]. Adv Drug Deliv Rev.


  1. Venkata Kashyap Yellepeddi (2018). Preservative-free prochlorperazine nasal spray for migraine therapy. U.S. Patent No. US 10,617,682 B2. Washington, D.C.:U.S. Patent and Trademark Office.